Vaccine inequity continues to be one of the greatest challenges in the pandemic - with only 10% of those in low- and middle-income countries fully vaccinated. One of the biggest hold-ups is a lack of vaccine manufacturing capacity in poorer nations. But now, researchers at the WHO technology-transfer hub have completed the first step in a project aimed at building vaccine manufacturing capacity in the Global South, by successfully replicating Moderna's COVID vaccine without assistance from the US-based biotech company. In this episode of Coronapod, we ask how they did it? What happens next? What the legal ramifications might be and what this could mean for the future of vaccine manufacture in low- and middle-income countries? Both during the pandemic and beyond.News: South African scientists copy Moderna's COVID vaccineNews: The fight to manufacture COVID vaccines in lower-income countriesEditorial: Africa is bringing vaccine manufacturing homeSubscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.

Hosted on Acast. See acast.com/privacy for more information.